Novel infectious diseases and emerging gram-positive multi-resistant pathogens in hospital and community acquired infections

Gian Maria Rossolini, Fabio Arena, Simona Pollini

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Gram-positive pathogens are a major cause of healthcare-associated and community-acquired bacterial infections. Staphylococci (mostly Staphylococcus aureus but also coagulase-negative staphylococci), enterococci, streptococci, and Clostridium difficile are the most important species of clinical interest. Antibiotic resistance issues are common among Gram-positive pathogens, especially among staphylococci and enterococci. Methicillin-resistant Staphylococcus aureus (MRSA) and glycopeptide-resistant enterococci (GRE) are paradigms for difficult-to-treat multi-resistant pathogen capable of global-scale diffusion, with remarkable impact on morbidity, mortality, and healthcare-associated costs. MRSA, in particular, is the most relevant Gram-positive multi-resistant pathogen in terms of diffusion and overall clinical impact, being a leading cause for healthcare-associated infections worldwide, as well as an emerging cause of community-acquired infections that are often associated with novel MRSA strains. Resistance to anti-MRSA and anti-VRE drugs remains uncommon or exceptional among the respective species. However, invasive infections caused by MRSA strains resistant to glycopeptides, linezolid, or daptomycin, and by VRE strains resistant to linezolid or daptomycin have increasingly been reported, especially after prolonged drug exposure, and a transferable resistance mechanism to linezolid and other anti-ribosomal agents has recently emerged among staphylococci and enterococci. This evolving scenario underscores the need for continuing efforts aimed at surveillance and control of infections caused by multi-resistant Gram-positives, and at the discovery and development of new drugs active against these pathogens.

Original languageEnglish
Title of host publicationAntimicrobials: New and Old Molecules in the Fight Against Multi-Resistant Bacteria
PublisherSpringer-Verlag Berlin Heidelberg
Pages11-28
Number of pages18
Volume9783642399688
ISBN (Print)9783642399688, 3642399673, 9783642399671
DOIs
Publication statusPublished - Nov 1 2014

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Fingerprint Dive into the research topics of 'Novel infectious diseases and emerging gram-positive multi-resistant pathogens in hospital and community acquired infections'. Together they form a unique fingerprint.

  • Cite this

    Rossolini, G. M., Arena, F., & Pollini, S. (2014). Novel infectious diseases and emerging gram-positive multi-resistant pathogens in hospital and community acquired infections. In Antimicrobials: New and Old Molecules in the Fight Against Multi-Resistant Bacteria (Vol. 9783642399688, pp. 11-28). Springer-Verlag Berlin Heidelberg. https://doi.org/10.1007/978-3-642-39968-8_2